ANAB - AnaptysBio, Inc.
About AnaptysBio, Inc. (https://www.anaptysbio.com)
AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products include Imsidolimab, an antibody that inhibits the interleukin-36 receptor (IL-36R) for the treatment of various dermatological inflammatory diseases; Rosnilimab, an anti-PD-1 agonist antibody program designed to augment PD-1 signaling through rosnilimab treatment to suppress T-cell driven human inflammatory diseases; and ANB032, an anti-BTLA modulator antibody applicable to human inflammatory diseases associated with lymphoid and myeloid immune cell dysregulation. The company also focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has a collaboration and license agreement with GlaxoSmithKline, Inc. and Bristol-Myers Squibb; and license agreements with United Kingdom Research and Innovation, as well as Millipore Corporation. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Daniel R. Faga | President, Chief Executive Officer & Director | 1980 | $1,196,289 USD |
| Paul F. Lizzul FAAD | Chief Medical Officer | 1975 | $795,198 USD |
| Eric J. Loumeau | Chief Legal Officer | 1963 | $722,002 USD |
| Christopher Murphy | Chief Financial Officer | 1984 | $673,635 USD |
| Dennis Mulroy | Chief Financial Officer | 1955 | $673,635 USD |
| Benjamin Stone | Chief Business Officer | 1991 | – |
| Beth Mueller | Senior Vice President of Human Resources | – | – |
| Cailin Sibley FACR | Senior Vice President of Translational Medicine | – | – |
| David McKeon | Senior Vice President & Controller | 1972 | – |
| John Kwon | Vice President of GI Clinical Development | – | – |
| Martin Dahl | Senior Vice President of Research | – | – |
| Monique Da Silva | Senior Vice President of Corporate Affairs | – | – |
| Priya Raina | Senior Vice President of Clinical Operations | – | – |